Since its inception, the PCF has contributed to significant advancements in prostate cancer research. These include the development of new biomarkers for early detection, advancements in imaging techniques, and the introduction of novel therapies such as immunotherapy and targeted treatments. The foundation's efforts have also led to the approval of several new drugs that improve patient outcomes.
